MBX

MBX Biosciences, Inc. is a clinical-stage precision endocrinology company developing peptide-based therapeutics for endocrine and metabolic disorders. The company focuses on diseases caused by hormonal imbalances, including hypoparathyroidism, post-bariatric hypoglycemia, and growth hormone deficiency. Their approach targets specific receptors to restore normal physiological function.